Convergence Investment Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-385
| Closed | -$19K | – | 554 |
|
|
2018
Q1 | $19K | Buy |
+385
| New | +$19K | ﹤0.01% | 604 |
|
|
2015
Q2 | – | Sell |
-4,046
| Closed | -$233K | – | 376 |
|
|
2015
Q1 | $233K | Buy |
4,046
+67
| +2% | +$3.86K | 0.03% | 338 |
|
|
2014
Q4 | $213K | Sell |
3,979
-15
| -0.4% | -$803 | 0.03% | 331 |
|
|
2014
Q3 | $230K | Buy |
3,994
+160
| +4% | +$9.21K | 0.03% | 331 |
|
|
2014
Q2 | $256K | Sell |
3,834
-1,784
| -32% | -$119K | 0.03% | 328 |
|
|
2014
Q1 | $375K | Sell |
5,618
-1,960
| -26% | -$131K | 0.06% | 290 |
|
|
2013
Q4 | $506K | Sell |
7,578
-1,452
| -16% | -$97K | 0.08% | 261 |
|
|
2013
Q3 | $566K | Sell |
9,030
-2,532
| -22% | -$159K | 0.12% | 196 |
|
|
2013
Q2 | $722K | Buy |
+11,562
| New | +$722K | 0.19% | 162 |
|